|
Becton Dickinson
monoclonal antibodies to cd86 (a dendritic cell marker) Monoclonal Antibodies To Cd86 (A Dendritic Cell Marker), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/anti+cd86/us06893633-218-16-23 Average 90 stars, based on 1 article reviews
monoclonal antibodies to cd86 (a dendritic cell marker) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Boster Bio
rabbit anti cd86 Rabbit Anti Cd86, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/Anti-CD86+(Dendritic+Cells+Maturation+Marker)+Monoclonal+Antibody/pmc12858484-58-4-6 Average 94 stars, based on 1 article reviews
rabbit anti cd86 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Revvity
anti human cd86 alexa 647 ![]() Anti Human Cd86 Alexa 647, supplied by Revvity, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/CD86+(human)%2C+lyophilized/pmc05515458-57-19-25 Average 91 stars, based on 1 article reviews
anti human cd86 alexa 647 - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Abcam
m1 macrophage marker cd86 ![]() M1 Macrophage Marker Cd86, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/Anti-CD86+antibody/pmc04347831-140-15-24 Average 99 stars, based on 1 article reviews
m1 macrophage marker cd86 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
cd86 ![]() Cd86, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/CD86+Rabbit+mAb/pmc12339349-134-42-43 Average 96 stars, based on 1 article reviews
cd86 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Proteintech
cd86 ![]() Cd86, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/CD86+Antibody/pm35265207-144-35-36 Average 96 stars, based on 1 article reviews
cd86 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Elabscience Biotechnology
apc cd86 ![]() Apc Cd86, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/APC+Anti-Human+CD86+Antibody/pmc09569602-177-15-16 Average 93 stars, based on 1 article reviews
apc cd86 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
SouthernBiotech
anti mouse cd86 ![]() Anti Mouse Cd86, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/Rat+Anti-Mouse+IgA-APC/pmc07067564-28-2-7 Average 93 stars, based on 1 article reviews
anti mouse cd86 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Thermo Fisher
gapdh fibronectin nckap1l gapdh nckap1l gapdh α sma gapdh collagen i gapdh flag gapdh gapdh nckap1l cd86 gapdh cd206 gapdh ![]() Gapdh Fibronectin Nckap1l Gapdh Nckap1l Gapdh α Sma Gapdh Collagen I Gapdh Flag Gapdh Gapdh Nckap1l Cd86 Gapdh Cd206 Gapdh, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/Collagen/pmc12097113__ADVS-12-2410764-s004-9-0-38 Average 99 stars, based on 1 article reviews
gapdh fibronectin nckap1l gapdh nckap1l gapdh α sma gapdh collagen i gapdh flag gapdh gapdh nckap1l cd86 gapdh cd206 gapdh - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Cytek Biosciences
cd86 pe ![]() Cd86 Pe, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/PE+Anti-Mouse+CD86/pmc07697542-126-14-15 Average 90 stars, based on 1 article reviews
cd86 pe - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
anti mouse cd86 rabbit mab ![]() Anti Mouse Cd86 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/CD86+Rabbit+mAb/pmc10943244-235-0-37 Average 97 stars, based on 1 article reviews
anti mouse cd86 rabbit mab - by Bioz Stars,
2026-11
97/100 stars
|
Buy from Supplier |
|
R&D Systems
rat anti mouse cd86 ![]() Rat Anti Mouse Cd86, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cd86+cell+surface+marker/Mouse+B7-2%2FCD86+Antibody/pmc08521441-60-15-23 Average 92 stars, based on 1 article reviews
rat anti mouse cd86 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
Image Search Results
Journal: PLoS ONE
Article Title: Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model
doi: 10.1371/journal.pone.0181553
Figure Lengend Snippet: CD14 + monocytes were matured to immature DC and incubated with medium (DC), maturation cocktail (DC Stim; 500 ng/mL LPS; 50 ng/mL TNF-alpha and 10 ng/mL IL-1beta), or VAEI (Iscador® Qu Spez; 0.5 μg/ml). After cultivation flow cytometric analysis of CD83 (A) , CD86 (B) and HLA-DR (C) expression was carried out. High CD83, CD86 and HLA-DR levels indicate DC maturation. MFI = Mean fluorescence intensity. Data and mean of 16 (DC Stim, CD83 and CD86), 13 (DC + VAEI, CD83 and CD86) or 5 (HLA-DR) individual experiments are presented in relation to untreated cells (DC = 100%). (D) The mediators IL-12p70, IL-6, IL-8 and TNFα were detected in the supernatants of cultured cells of 6 independent experiments and analyzed using cytokine bead array assay. Asterisks indicate significant differences between the groups (*P < 0.05, **P < 0.01, ***P < 0.001).
Article Snippet: The surface marker expression of dendritic cells was analyzed by microscopy after staining with anti-human HLA-DR Alexa 488 and
Techniques: Incubation, Expressing, Fluorescence, Cell Culture
Journal: PLoS ONE
Article Title: Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model
doi: 10.1371/journal.pone.0181553
Figure Lengend Snippet: CD14 + monocytes were matured to immature DC and incubated with medium (DC), maturation cocktail (DC Stim; 500 ng/mL LPS; 50 ng/mL TNF-alpha and 10 ng/mL IL-1beta), or VAEA (DC + VAEA; abnobaVISCUM® Fraxini; 0.06 μg/ml). After cultivation flow cytometric analysis of CD83 (A), CD86 (B) and HLA-DR (C) expression was carried out. High CD83, CD86 and HLA-DR levels indicate DC maturation. MFI = Mean fluorescence intensity. Data and mean of 16 (DC Stim, CD83 and CD86) and 6 (DC + VAEA, CD83 and CD86) or 5 (HLA-DR) individual experiments are presented in relation to untreated cells (DC = 100%). (D) The mediators IL-12p70, IL-6, IL-8 and TNFα were detected in the supernatants of cultured cells of 6 independent experiments and analyzed using cytokine bead array assay. Asterisks indicate significant differences between the groups (*P < 0.05, **P < 0.01, ***P < 0.001).
Article Snippet: The surface marker expression of dendritic cells was analyzed by microscopy after staining with anti-human HLA-DR Alexa 488 and
Techniques: Incubation, Expressing, Fluorescence, Cell Culture
Journal: PLoS ONE
Article Title: Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model
doi: 10.1371/journal.pone.0181553
Figure Lengend Snippet: CD14 + monocytes were matured to immature DC and incubated with medium (DC), maturation cocktail (DC Stim; 500 ng/mL LPS; 50 ng/mL TNF-alpha and 10 ng/mL IL-1beta), VAEI (DC + VAEI; Iscador® Qu Spez; 0.5 μg/ml) or VAEA (DC + VAEA; abnobaVISCUM® Fraxini; 0.06 μg/ml). After cultivation automated fluorescence microscopy and analysis of HLA-DR (A) and CD86 (B) expression was carried out. High HLA-DR and CD86 levels indicate DC maturation. MFI = Mean fluorescence intensity. Data and mean of 4 individual experiments are presented in relation to untreated cells (DC = 100%). Asterisks indicate significant differences between the groups (*P < 0.05, **P < 0.01, ***P < 0.001).
Article Snippet: The surface marker expression of dendritic cells was analyzed by microscopy after staining with anti-human HLA-DR Alexa 488 and
Techniques: Incubation, Fluorescence, Microscopy, Expressing
Journal: PLoS ONE
Article Title: Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model
doi: 10.1371/journal.pone.0181553
Figure Lengend Snippet: Dendritic cells derived from CD14 + monocytes were cultured in medium alone (DC) or supplemented with VAEI (DC + VAEI; Iscador® Qu Spez; 0.5 μg/ml), ML-depleted VAEI (DC + VAEI-ML; Iscador®; 0.66 μg/ml) or VAEI and anti-ML antibody (DC + VAEI + aML-Ab). DC maturation was assessed by flow cytometric analysis of CD83 (A) , CD86 (B) and HLA-DR (C) expression. MFI = Mean fluorescence intensity. Data and mean of 13 (DC + VAEI; CD83 and CD86), 3 (DC + VAEI-ML and DC + VAEI + aML-Ab; CD83 and CD86) or 5 (HLA-DR) individual experiments are represented in relation to untreated cells (DC = 100%) or VAEI-treated DC (DC + VAEI = 100%). Asterisks indicate significant differences between the groups (*P < 0.05, **P < 0.01, ***P < 0.001).
Article Snippet: The surface marker expression of dendritic cells was analyzed by microscopy after staining with anti-human HLA-DR Alexa 488 and
Techniques: Derivative Assay, Cell Culture, Expressing, Fluorescence
Journal: PLoS ONE
Article Title: Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model
doi: 10.1371/journal.pone.0181553
Figure Lengend Snippet: Dendritic cells derived from CD14 + monocytes were stimulated with maturation cocktail (DC Stim; 500 ng/mL LPS; 50 ng/mL TNF-alpha and 10 ng/mL IL-1beta) and incubated with IL-6 as an inhibition positive control (DC Stim + IL-6; 12.5 ng/ml). Unstimulated DC were further treated with 10% RPMI 1640 medium (DC + Medium), 10% tumor supernatant of an RCC line (DC + TS) or 10% tumor supernatant and VAEI (DC + TS + VAEI; Iscador® Qu Spez; 0.5 μg/ml) or VAEA (DC + TS + VAEA; abnobaVISCUM® Fraxini; 0.06 μg/ml). DC maturation was assessed by flow cytometric analysis of CD83 (A) and CD86 (B) surface marker expression. MFI = Mean fluorescence intensity. Data and mean of 7 (IL-6 and DC + TS + VAEA), 16 (DC + TS) or 9 (DC + TS + VAEI) individual experiments are presented in relation to stimulated cells (DC Stim = 100%), stimulated DC cultured in medium alone (DC + Medium = 100%) or stimulated cells cultured with tumor supernatant (DC + TS = 100%). Asterisks indicate significant differences between the groups (*P < 0.05, **P < 0.01, ***P < 0.001).
Article Snippet: The surface marker expression of dendritic cells was analyzed by microscopy after staining with anti-human HLA-DR Alexa 488 and
Techniques: Derivative Assay, Incubation, Inhibition, Positive Control, Marker, Expressing, Fluorescence, Cell Culture
Journal: PLoS ONE
Article Title: Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model
doi: 10.1371/journal.pone.0181553
Figure Lengend Snippet: Dendritic cells derived from CD14 + monocytes were incubated with 10% tumor supernatant (DC + TS). Further treatment of DC + TS was carried out with VAEI (DC + TS + VAEI; Iscador® Qu Spez; 0.5 μg/ml), ML-depleted VAEI (DC + TS + VAEI-ML; Iscador®; 0.66 μg/ml), or VAEI and anti-ML antibody (DC + TS + VAEI + aML-Ab; 2.5 μg/ml). DC maturation was assessed by flow cytometric analysis of CD83 (A), CD86 (B) and HLA-DR (C) expression. MFI = Mean fluorescence intensity. Data and mean of 12 (DC + TS + VAEI), 3 (DC + TS + VAEI-ML and DC + TS + VAEI + aML-Ab) or 5 (HLA-DR) individual experiments are presented in relation to stimulated and TS-treated cells (DC + TS = 100%), or TS and VAEI-treated DC (DC + TS + VAEI = 100%). Asterisks indicate significant differences between the groups (*P < 0.05, **P < 0.01, ***P < 0.001).
Article Snippet: The surface marker expression of dendritic cells was analyzed by microscopy after staining with anti-human HLA-DR Alexa 488 and
Techniques: Derivative Assay, Incubation, Expressing, Fluorescence
Journal: PLoS ONE
Article Title: Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model
doi: 10.1371/journal.pone.0181553
Figure Lengend Snippet: Unstimulated CD14 + -derived DC were treated with 10% RPMI 1640 medium (DC + Medium), 10% tumor supernatant of an RCC line (DC + TS) or 10% tumor supernatant and VAEI (DC + TS + VAEI; Iscador® Qu Spez; 0.5 μg/ml), ML-depleted VAEI (DC + TS + VAEI-ML; Iscador®; 0.66 μg/ml), or VAEI and anti-ML antibody (DC + TS + VAEI + aML-Ab; 2.5 μg/ml). After cultivation automated fluorescence microscopy and quantitative analysis of HLA-DR (A) and CD86 (B) expression was carried out. MFI = Mean fluorescence intensity. Data and mean of 4 individual experiments are presented in relation to untreated cells (DC = 100%). Asterisks indicate significant differences between the groups (*P < 0.05, **P < 0.01, ***P < 0.001).
Article Snippet: The surface marker expression of dendritic cells was analyzed by microscopy after staining with anti-human HLA-DR Alexa 488 and
Techniques: Derivative Assay, Fluorescence, Microscopy, Expressing
Journal: Theranostics
Article Title: Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model.
doi: 10.7150/thno.70756
Figure Lengend Snippet: Figure 6. PBM treatment promotes microglial polarization from M1 to M2 phenotype. (A) Representative confocal microscopy images and 3D reconstruction images of Iba-1 with M1 marker CD16/32 or the M2 marker CD 206 in both the cortex and hippocampus. The relative fluorescent intensities of CD16/32 and CD206 were analyzed using Image J. Data are presented as mean ± SEM (n = 5). Rectangles indicate cells enlarged and 3D-rendered in the bottom row. Scale bar = 20 µm. (B) Western blotting analysis of M1 phenotype markers (i.e., CD32, CD86, and iNOS) and M2 phenotype markers (i.e., TGFβ and ARG). Data are presented as mean ± SEM (n = 4). (C) Immunofluorescence staining of Iba-1 with M1 marker CD16/32 or the M2 marker CD 206 in vitro cell culture. Scale bar = 20 µm. Data are presented as mean ± SEM (n = 6). *P < 0.05 versus WT group, # P < 0.05 versus AD or Aβ1-42 group.
Article Snippet: After incubation with 3% bovine serum albumin (BSA) for 30 min, the membranes were then incubated at 4 °C overnight with the following antibodies: Bax (Abcam), PSD95 (Thermo Fisher), spinophilin (Abcam), synaptophysin (Abcam), GAPDH (Abcam),
Techniques: Confocal Microscopy, Marker, Western Blot, Immunofluorescence, Staining, In Vitro, Cell Culture
Journal: International Journal of Molecular Sciences
Article Title: Hepatocyte-Derived Prostaglandin E2-Modulated Macrophage M1-Type Polarization via mTOR-NPC1 Axis-Regulated Cholesterol Transport from Lysosomes to the Endoplasmic Reticulum in Hepatitis B Virus x Protein-Related Nonalcoholic Steatohepatitis
doi: 10.3390/ijms231911660
Figure Lengend Snippet: Regulation of macrophage polarization by the mTOR-NPC1-ERO1α pathway was verified in HBx-Tg mouse ex vivo assay. Primary hepatocytes (PHCs) and primary macrophages (PMCs) were co-cultured by HBx-Tg mouse liver perfusion isolation. Rapamycin (Rapa), U18666A, and EN460 were used to establish the inhibition of mTOR, NPC1, and ERO1α in PMCs. ( A ) WB detection of HBx and COX-2 protein levels in PHCs; mTOR, NPC1, ERO1α, and polarization marker protein levels in PMCs. ( B – D ) ELISA detection of PGE2 levels ( B ), ox-LDL levels ( C ), and IL-6 levels ( D ) in the supernatant. ( E ) Flow cytometry detection of M1/M2-polarized phenotypes. ( F ) Quantitative analysis of M1(CD86)/M2(CD206) polarization. The data are presented as the mean ± SD. * p < 0.05, compared with the WT group. # p < 0.05, compared with the HBx group.
Article Snippet: Cell staining: A total of 5 μL each of flow-through antibodies PerCP/Cyanine5.5-F4/80, FITC-CD11b, PE-CD206, and
Techniques: Ex Vivo, Cell Culture, Isolation, Inhibition, Marker, Enzyme-linked Immunosorbent Assay, Flow Cytometry
Journal: International Journal of Molecular Sciences
Article Title: Hepatocyte-Derived Prostaglandin E2-Modulated Macrophage M1-Type Polarization via mTOR-NPC1 Axis-Regulated Cholesterol Transport from Lysosomes to the Endoplasmic Reticulum in Hepatitis B Virus x Protein-Related Nonalcoholic Steatohepatitis
doi: 10.3390/ijms231911660
Figure Lengend Snippet: EP4 intervention rescued hepatic macrophage polarization imbalance in vivo. ( A – C ) PMCs were isolated by liver perfusion from different HBx-Tg mouse models. ( A ) Flow cytometry of the M1/M2 polarization phenotype in mononuclear-derived Kupffer cells. ( B ) Quantitative analysis of M1(CD86)/M2(CD206) polarization. ( C ) WB detection of EP4, iNOS, and CD206 in PMCs. ( D ) Representative images of the IHC staining of F4/80, iNOS, and CD206 in liver tissue sections are shown. Scale bar 100 μm. ( E , F ) ELISA detection of IL-6 levels in serum ( E ) and livers ( F ). The data are presented as the mean ± SD. * p < 0.05, compared with the HBx group. # p < 0.05, compared with the HBx + HFCD group.
Article Snippet: Cell staining: A total of 5 μL each of flow-through antibodies PerCP/Cyanine5.5-F4/80, FITC-CD11b, PE-CD206, and
Techniques: In Vivo, Isolation, Flow Cytometry, Derivative Assay, Immunohistochemistry, Enzyme-linked Immunosorbent Assay
Journal: eLife
Article Title: Metabolic and non-metabolic liver zonation is established non-synchronously and requires sinusoidal Wnts
doi: 10.7554/eLife.46206
Figure Lengend Snippet: ( A ) Experimental strategy for Cldn2-EGFP mice injected with CCl 4 . ( B ) ( No CCl 4 ) Results of double-immunofluorescence analysis show expression of the pan-macrophage marker F4/80 + in Kupffer cells (arrowheads) in a control adult liver (no CCl 4 injection). ( Day 2–5 ) In the CCl 4 -injected Cldn2-EGFP liver, macrophages (arrows) start to infiltrate the necrotic perivenous area at day two and form a physical barrier between the central vein endothelium and the expanding GFP + Zone 2 at days 3 and 5. Resolution of macrophage perivenous infiltrates and restoration of claudin-2/GFP expression occur 7 days post-CCl 4 injection (arrows are Kupffer cells). ( C ) ( No CCl 4 ) M1 macrophages (CD86 + ) are not detected in perivenous or periportal regions in Cldn2-EGFP control mice ( C is central vein, P is portal vein). ( Day 2–5, top ) Immunofluorescence images of CCl 4 -injected Cldn2-EGFP livers showing increasingly abundant infiltrates of CD86+ macrophages (arrows) 2 days post-CCl 4 and persistence of these cells around the central veins at days 3 and 5. CD86 + macrophages are no longer present in perivenous areas at day 7 ( CV , central vein region). ( Day 2–5, bottom ) CD86 + macrophages are very scarce in periportal areas in CCl 4 -injected livers ( PV , portal vein region). (The exposure in the green channel was decreased for better visualization of the red [CD86] signal. ( D ) Macrophages infiltrating the perivenous region do not express the M2 macrophage marker CD206 3 days post-CCl4 injection (arrowheads indicate low expression of this marker in LSECs). ( E ) Quantification of F4/80 + immunofluorescence distribution 2-, 3- and 5 days post-CCl 4 . p values were determined by one-way ANOVA with Bonferroni’s multiple comparisons test. **p<0.01, ***p<0.001. 3–4 representative fields from three individual livers dissected at the indicated time points were used for quantification. Asterisks and C , central veins. P, portal veins. CV , central vein area. PV , portal vein area. ( F ) A few CD86 + macrophages are seen within the Lyve1 + hepatic sinusoids in periportal areas of the CCl 4 injected liver. CD86 + macrophages are overabundant in perivenous areas (right, ‘C’, arrowhead) in comparison to periportal areas (‘P’). Each image represents 3–4 individual livers. Scale bars: 100 μm ( B ), ( C ) [no CCl 4 , Days 2,7]) Scale bars: 50 μm ( C ) [Days 3,5], ( D,F ). Figure 5—source data 1. Quantification of F4/80 + immunofluorescence distribution post-CCl 4 injection.
Article Snippet: Antibody ,
Techniques: Injection, Immunofluorescence, Expressing, Marker, Control, Comparison
Journal: eLife
Article Title: Metabolic and non-metabolic liver zonation is established non-synchronously and requires sinusoidal Wnts
doi: 10.7554/eLife.46206
Figure Lengend Snippet:
Article Snippet: Antibody ,
Techniques: Imaging, cDNA Synthesis, Activity Assay, Plasmid Preparation, Western Blot, RNAscope, Positive Control, Negative Control, Sequencing, Cell Culture, Protease Inhibitor, Recombinant, Mutagenesis, Software
Journal: Microorganisms
Article Title: Exosomes of Epstein-Barr Virus-Associated Gastric Carcinoma Suppress Dendritic Cell Maturation
doi: 10.3390/microorganisms8111776
Figure Lengend Snippet: Differential effects of exosomes secreted by EBV-infected gastric cancer cells on the maturation phenotype of human monocyte-derived dendritic cells (moDCs). Immature DCs were either untreated or treated with the indicated exosomes or with LPS as a positive control for maturation. ( A ) Phase-contrast images of moDCs cultured with exosomes in EBV-infected cells. Large aggregates of cells (arrows) as reported for mature moDCs were found in MKN74-derived exome-treated moDCs but not in EBV-positive cell-derived exosome-treated cells. ( B ) Flow cytometry results of CD1a and CD86 on moDCs incubated with the indicated exosomes. The data are presented as % positive cells of indicated markers. The results are representative of three independent experiments from different donors.
Article Snippet: The primary antibodies used were CD1a-PE (BioLegend, San Diego, CA, USA, clone HI149) and
Techniques: Infection, Derivative Assay, Positive Control, Cell Culture, Flow Cytometry, Incubation
Journal: Microorganisms
Article Title: Exosomes of Epstein-Barr Virus-Associated Gastric Carcinoma Suppress Dendritic Cell Maturation
doi: 10.3390/microorganisms8111776
Figure Lengend Snippet: Representative figures of dendritic cells expressing each DC marker in gastric cancer tissue. DCs expressing Langerin, CD1a, and S100 were identified as cells with abundant dendrites. DCs expressing BDCA-2, CD83, and CD86 were identified as relatively small round cells (arrowhead). More abundant infiltration of dendritic cells in EBVaGC was observed than in EBV-negative gastric cancer for each DC marker. Immunohistochemical analysis of Langerin, CD1a, S100, CD83, CD86 and BDCA. Scale bar: 50 µm.
Article Snippet: The primary antibodies used were CD1a-PE (BioLegend, San Diego, CA, USA, clone HI149) and
Techniques: Expressing, Marker, Immunohistochemical staining
Journal: Microorganisms
Article Title: Exosomes of Epstein-Barr Virus-Associated Gastric Carcinoma Suppress Dendritic Cell Maturation
doi: 10.3390/microorganisms8111776
Figure Lengend Snippet: Number of dendritic cells that infiltrated gastric cancer tissue. Dendritic cells expressing each DC marker were counted, and the number per tumor area is shown. The number of DCs is significantly higher in EBVaGC than in EBV-negative gastric cancer for any of the DC markers ( p < 0.001 for Langerin, CD1a, CD83, CD86, and BDCA-2. p < 0.05 for S100, determined by using Wilcoxon rank sum test).
Article Snippet: The primary antibodies used were CD1a-PE (BioLegend, San Diego, CA, USA, clone HI149) and
Techniques: Expressing, Marker
Journal: Microorganisms
Article Title: Exosomes of Epstein-Barr Virus-Associated Gastric Carcinoma Suppress Dendritic Cell Maturation
doi: 10.3390/microorganisms8111776
Figure Lengend Snippet: Correlation between the number of dendritic cells per tumor area and clinicopathological factors.
Article Snippet: The primary antibodies used were CD1a-PE (BioLegend, San Diego, CA, USA, clone HI149) and
Techniques:
Journal: Microorganisms
Article Title: Exosomes of Epstein-Barr Virus-Associated Gastric Carcinoma Suppress Dendritic Cell Maturation
doi: 10.3390/microorganisms8111776
Figure Lengend Snippet: Mature DC ratio in DC-high and DC-low cases. CD83/CD1a ratio and CD86/CD1a ratios were significantly lower in CD1a-high cases than in CD1a-low cases ( A , p < 0.01, determined by using Wilcoxon rank sum test). The similar result was also obtained in Langerin ( B , p = 0.08 and p = 0.005, respectively, Wilcoxon rank sum test).
Article Snippet: The primary antibodies used were CD1a-PE (BioLegend, San Diego, CA, USA, clone HI149) and
Techniques:
Journal: Nature Communications
Article Title: Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy
doi: 10.1038/s41467-024-46210-1
Figure Lengend Snippet: a Illustration of engineering process of BMDM and the polarization of eBMDM by wireless-controlled secretion of IFN-γ. b The increase of IFN-γ by eBMDM after HS at 42 °C for 30 min. c The increment of IFN-γ by eBMDM after HS at 42 °C for 30 min at day 1 and day 3, respectively. The green arrow in ( b ) and ( c ) refers to the time point of HS. d Flow cytometry analysis and ( e ) quantitative analysis of CD86 + macrophages in eBMDM after the indicated treatment. RT-qPCR analysis of M1 macrophages markers ( f ) and M2 macrophages markers ( g ) after the indicated treatment. IFN-γ treated BMDMs and IL-4-treated BMDMs were used as positive controls. h Illustration of proinflammatory cytokines-mediated inhibition of tumor proliferation by using Transwell system. i Proinflammatory cytokines-mediated inhibition of tumor proliferation was determined by CCK8 assay with the indicated treatment. j Illustration of the phagocytosis of B16F10 cells by polarized M1 eBMDM. k , l Flow cytometry and quantitative analysis of the phagocytosis of BMDMs after the specified treatment. m Fluorescence images of the phagocytosis by BMDMs. B16F10 cells were labeled with CFSE (green), the cell membrane of eBMDM was labeled with DiI (red), and the nuclei of both cells were stained with DAPI (blue). The white arrows point to the B16F10 cell phagocytized by macrophages. n Illustration of the chemotaxis of eBMDM by Transwell assay. o The tumor-targeting tropism was evaluated by the number of BMDMs that migrates through the semipermeable membrane. p Quantitative analysis of cell migration ability in ( o ) after the specified treatment. CM stands for culture medium. Data are presented as mean ± SD, n = 3 biologically independent samples in ( b – o ). Statistical significance was calculated via two-tailed paired t -test in ( b ) and one-way ANOVA with a Sidak’s multiple comparisons in ( e ) and one-way ANOVA with a Tukey’s multiple comparisons test in ( i ), ( l ) and ( p ). * P < 0.05; ** P < 0. 01; *** P < 0.001; **** P < 0.0001. Source data are provided as a Source Data file.
Article Snippet:
Techniques: Flow Cytometry, Quantitative RT-PCR, Inhibition, CCK-8 Assay, Fluorescence, Labeling, Membrane, Staining, Chemotaxis Assay, Transwell Assay, Migration, Two Tailed Test
Journal: Nature Communications
Article Title: Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy
doi: 10.1038/s41467-024-46210-1
Figure Lengend Snippet: RT-qPCR analysis of M1 ( a ) and M2 ( b ) macrophages markers in tumor tissues after the indicated treatment. c Flow cytometry analysis of the polarization of macrophages in tumor tissues after the indicated treatment. CD86 + is the marker of M1 macrophages, while CD206 + is the marker of M2 macrophages. d Quantitative analysis of the M1/M2 ratio of macrophages in ( c ). e Flow cytometry analysis the CD8 + T cells in tumor tissues after eBMDM treatment with or without heat shock. f , g Quantitative analysis of the ratio of CD8 + T cells in CD45 + cells and CD3 + cells. h IFN-γ and TNF-α levels in tumor tissues collected from mice after the indicated treatment. i IL-4 and IL-10 levels in tumor tissues collected from mice after the indicated treatment. j Multiplex IHC images of M1 macrophage and eBMDM infiltration in tumor tissues. In merged figures, DiI-positive and CD86-positive cells (orange) represent M1 eBMDM, CD86-positive only cells (green) represent re-polarized TAMs. k IHC images of M2 macrophage infiltration in tumor tissues. Data are presented as mean ± SD, n = 3 biologically independent samples in ( a – k ). Statistical significance was calculated via one-way ANOVA with a Sidak’s multiple comparisons in ( d ) and one-way ANOVA with a Tukey’s multiple comparison tests in ( f – i ). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Source data are provided as a Source Data file.
Article Snippet:
Techniques: Quantitative RT-PCR, Flow Cytometry, Marker, Multiplex Assay, Comparison
Journal: Nature Communications
Article Title: Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy
doi: 10.1038/s41467-024-46210-1
Figure Lengend Snippet: a Illustration of macrophage depletion and adoptive eBMDM therapy with wireless iWarm in vivo. b In vivo bioluminescence images of mice after the specified treatment at day 16. c , d The inhibition of tumor growth of tumor-bearing mice after the indicated treatment. e The survival curve of tumor-bearing mice after the indicated treatment. f Flow cytometry analysis the macrophages infiltration in tumor tissues after the indicated treatment. CD11b + F4/80 + is the marker of macrophages. g The quantitative analysis of F4/80 + CD86 + macrophages in tumor tissues after the indicated treatment by flow cytometry. h Multiplex IHC images of macrophage and eBMDM infiltration in tumor tissues. i Flow cytometry analysis the CD4 + T cells and CD8 + T cells in tumor tissues after the indicated treatment. The quantitative analysis of the ratio of CD4 + T cells ( j ) and CD8 + T cells ( k ) in tumor tissues after the indicated treatment by flow cytometry. l IFN-γ levels in tumor tissues collected from mice after the indicated treatment. Data are presented as mean ± SD, n = 4 biologically independent mice in ( b – d ); n = 10 biologically independent mice in ( e ), and n = 3 biologically independent samples in ( g – l ). Statistical significance was calculated via one-way ANOVA with a Tukey’s multiple comparison tests in ( d ), ( g ), and ( j – l ). * P < 0.05; ** P < 0. 01; *** P < 0.001; **** P < 0.0001. Source data are provided as a Source Data file.
Article Snippet:
Techniques: In Vivo, Inhibition, Flow Cytometry, Marker, Multiplex Assay, Comparison
Journal: Nature Communications
Article Title: Proinflammatory polarization of engineered heat-inducible macrophages reprogram the tumor immune microenvironment during cancer immunotherapy
doi: 10.1038/s41467-024-46210-1
Figure Lengend Snippet: a Illustration of IFN-γ neutralization and adoptive eBMDM therapy with wireless iWarm in vivo. b In vivo bioluminescence images of mice after the specified treatment at day 11. Average ( c ) and individual ( d ) tumor growth curves after the specified treatment. e IFN-γ levels in tumor tissues collected from mice after the indicated treatment. Flow cytometry analysis the M1 polarization ( f ) and the M2 polarization ( h ) of macrophages in tumor tissues after the indicated treatment. CD86 + is the marker of M1 macrophages, while CD206 + is the marker of M2 macrophages. Quantitative analysis of the M1 ( g ) and M2 ( i ) ratio of macrophages in ( e ) and ( g ). j Flow cytometry analysis the CD8 + T cells in tumor tissues after the indicated treatment. k Quantitative analysis of the ratio of CD8 + T cells. Data are presented as mean ± SD, n = 3 biologically independent mice or samples in ( a – k ). Statistical significance was calculated via two-tailed unpaired t -test in ( c ) and one-way ANOVA with a Tukey’s multiple comparison tests in ( e ), ( g ), ( i ), and ( k ). * P < 0.05; ** P < 0.01; *** P < 0.001; **** P < 0.0001. Source data are provided as a Source Data file.
Article Snippet:
Techniques: Neutralization, In Vivo, Flow Cytometry, Marker, Two Tailed Test, Comparison
Journal: Journal of Inflammation Research
Article Title: Distinct Polarization Dynamics of Microglia and Infiltrating Macrophages: A Novel Mechanism of Spinal Cord Ischemia/Reperfusion Injury
doi: 10.2147/JIR.S335382
Figure Lengend Snippet: Primers of Genes Used in PCR Analysis
Article Snippet: For immunofluorescence, primary antibodies included rabbit anti-mouse CD11b (1:100, Affinity, OH, US) to mark macrophage/microglia,
Techniques:
Journal: Journal of Inflammation Research
Article Title: Distinct Polarization Dynamics of Microglia and Infiltrating Macrophages: A Novel Mechanism of Spinal Cord Ischemia/Reperfusion Injury
doi: 10.2147/JIR.S335382
Figure Lengend Snippet: Dynamic changes in M1 and M2 phenotypes of macrophages following SCIRI. ( A ) The immuno-fluorescence staining of CD11b + (green), CD86 + (red) and CD206 + (red) at P1, P3 and P7 after SCIRI. Scale bar = 100μm, n = 3 for each time point. ( B ) Quantification of CD11b +, CD86 + and CD206 + expressions at P1, P3 and P7 after SCIRI. *Represented P < 0.05 compared with the Sham group. **Represented P < 0.01 compared with the Sham group.
Article Snippet: For immunofluorescence, primary antibodies included rabbit anti-mouse CD11b (1:100, Affinity, OH, US) to mark macrophage/microglia,
Techniques: Fluorescence, Staining
Journal: Journal of Inflammation Research
Article Title: Distinct Polarization Dynamics of Microglia and Infiltrating Macrophages: A Novel Mechanism of Spinal Cord Ischemia/Reperfusion Injury
doi: 10.2147/JIR.S335382
Figure Lengend Snippet: Colocalization of CD11b and CD86 (or CD206). Double immunofluorescence confirmed that both CD86 (red) and CD206 (red) were mainly accumulated in CD11b (green) positive cells. scale bar = 25μm.
Article Snippet: For immunofluorescence, primary antibodies included rabbit anti-mouse CD11b (1:100, Affinity, OH, US) to mark macrophage/microglia,
Techniques: Immunofluorescence
Journal: Journal of Inflammation Research
Article Title: Distinct Polarization Dynamics of Microglia and Infiltrating Macrophages: A Novel Mechanism of Spinal Cord Ischemia/Reperfusion Injury
doi: 10.2147/JIR.S335382
Figure Lengend Snippet: Microglia and invading MDMs display distinct patterns of polarization during SCIRI. ( A ) Examples of flow cytometry analysis of the spinal cord are shown, identifying monocyte-derived macrophages (MDMs) and microglia as CD45 + CD11b high and CD45 + CD11b low , respectively. ( B ) Spontaneous infiltration of circulating monocytes to the spinal cord increased after SCIRI. ( C – F ) Quantification of expression of CD86 ( C and E ), Dectin ( D and F ) in MDMs and microglia in spinal cord after SCIRI. Cells were pooled from 3 mice per group for a total of 3 separate experiments for each time point. * P < 0.05, ** P < 0.01 compared with the Sham group.
Article Snippet: For immunofluorescence, primary antibodies included rabbit anti-mouse CD11b (1:100, Affinity, OH, US) to mark macrophage/microglia,
Techniques: Flow Cytometry, Derivative Assay, Expressing